0001640455-18-000100.txt : 20180815 0001640455-18-000100.hdr.sgml : 20180815 20180815172802 ACCESSION NUMBER: 0001640455-18-000100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180813 FILED AS OF DATE: 20180815 DATE AS OF CHANGE: 20180815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cole Hugh M CENTRAL INDEX KEY: 0001604646 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37998 FILM NUMBER: 181021824 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS, INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jounce Therapeutics, Inc. CENTRAL INDEX KEY: 0001640455 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 454870634 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-3840 MAIL ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_153436846547519.xml FORM 4 X0306 4 2018-08-13 0 0001640455 Jounce Therapeutics, Inc. JNCE 0001604646 Cole Hugh M C/O JOUNCE THERAPEUTICS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 0 1 0 0 Chief Business Officer Common Stock 2018-08-13 4 A 0 14400 0 A 16300 D /s/ Anna L. Barry, Attorney-in-Fact 2018-08-15